MaxCyte Inc (NAS:MXCT)
$ 4.17 0.07 (1.71%) Market Cap: 448.57 Mil Enterprise Value: 310.84 Mil PE Ratio: 0 PB Ratio: 1.94 GF Score: 77/100

Q3 2023 MaxCyte Inc Earnings Call Transcript

Nov 08, 2023 / 09:30PM GMT
Release Date Price: $3.35 (-1.47%)
Operator

Good day, and thank you for standing by, and welcome to the MaxCyte Third Quarter Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to introduce your host for today's call, Sean Menarguez, Senior Director of Innovation and Business Development. Please go ahead.

Sean Menarguez
MaxCyte, Inc. - Director of IR

Well, thank you, Justin, and good afternoon, everyone. My name is Sean Menarguez. I'm the Director of Innovation and Business Development here at MaxCyte. Thank you all for participating in today's conference call.

On the call from MaxCyte we have Douglas Doerfler, President and Chief Executive Officer; and Douglas J. Swirsky, Chief Financial Officer. Earlier today, MaxCyte released financial results for the third quarter ended September 30, 2023. A copy of the press release is available on the company's website.

Before we begin, I need to read the following statement. Statements or comments made during this call may be forward-looking statements within

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot